Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China flag China · Delayed Price · Currency is CNY
4.320
+0.060 (1.41%)
Nov 17, 2026, 3:00 PM CST

SHA:600866 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
15,52315,29316,71016,89117,0743,970
Other Revenue
607.51607.51624.13482.72412.8100.95
16,13015,90017,33417,37417,4864,071
Revenue Growth
-2.96%-8.27%-0.23%-0.64%329.51%264.72%
Cost of Revenue
14,70013,35014,39314,97614,4883,276
Gross Profit
1,4302,5502,9422,3972,998794.87
Selling, General & Admin
1,0741,0711,076947.17935.84365.04
Research & Development
179.71182.02169.78179.31177.9898.83
Other Operating Expenses
106.56107.18104.9780.35118.98.21
Operating Expenses
1,3721,3701,3461,2131,236469.21
Operating Income
58.761,1801,5961,1851,762325.66
Interest Expense
-87.55-80.71-109.68-173.46-243.29-83.35
Interest & Investment Income
44.9452.0114.8521.4315.57.26
Currency Exchange Gain (Loss)
21.4121.4137.4-8.33-76.916.6
Other Non Operating Income (Expenses)
-45.14-5.64-19.65-14.12-40.354.97
EBT Excluding Unusual Items
-7.571,1671,5191,0101,417261.14
Impairment of Goodwill
---91.91-93.7-12.34-
Gain (Loss) on Sale of Investments
1.0420.78-237.67-66.943.68.79
Gain (Loss) on Sale of Assets
0.01-5.2928.690.34.350.83
Asset Writedown
4.02-13.36-6.9-14.15-17.14-4.31
Other Unusual Items
49.4249.4221.9227.8827.7211.81
Pretax Income
46.911,2181,233863.621,424278.26
Income Tax Expense
22.7248.21283.27177.92240.5629.18
Earnings From Continuing Operations
24.22970.04949.81685.71,183249.07
Minority Interest in Earnings
-4.548.85-6.66-7.74-574.66-96.94
Net Income
19.67978.89943.15677.95608.33152.14
Net Income to Common
19.67978.89943.15677.95608.33152.14
Net Income Growth
-98.46%3.79%39.12%11.45%299.85%2.31%
Shares Outstanding (Basic)
1,6631,6611,6611,6621,188807
Shares Outstanding (Diluted)
1,6631,6611,6611,6621,188807
Shares Change
0.12%0.00%-0.02%39.91%47.23%9.14%
EPS (Basic)
0.010.590.570.410.510.19
EPS (Diluted)
0.010.590.570.410.510.19
EPS Growth
-98.47%3.79%39.14%-20.34%171.58%-6.26%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,314-746.521,7591,6501,210-181.59
Free Cash Flow Per Share
-1.39-0.451.060.991.02-0.23
Dividend Per Share
0.3800.3800.3800.380--
Dividend Growth
0%0%0%---
Gross Margin
8.87%16.04%16.97%13.80%17.15%19.52%
Operating Margin
0.36%7.42%9.21%6.82%10.08%8.00%
Profit Margin
0.12%6.16%5.44%3.90%3.48%3.74%
Free Cash Flow Margin
-14.34%-4.70%10.15%9.50%6.92%-4.46%
EBITDA
888.22,0132,4342,0352,742429.11
EBITDA Margin
5.51%12.66%14.04%11.71%15.68%10.54%
D&A For EBITDA
829.44833.19838.18850.63979.49103.45
EBIT
58.761,1801,5961,1851,762325.66
EBIT Margin
0.36%7.42%9.21%6.82%10.08%8.00%
Effective Tax Rate
48.38%20.38%22.97%20.60%16.90%10.49%
Revenue as Reported
16,13015,90017,33417,37417,4864,071
Advertising Expenses
-2051.0562.4217.74.96